Annual Report 2010 of the Galenica Group and Galenica Ltd

Total Page:16

File Type:pdf, Size:1020Kb

Annual Report 2010 of the Galenica Group and Galenica Ltd AnnuAl report 2010 of the galenica group and galenica ltd. the galenica group – excellence in the healthcare market WorldReginfo - 721ec6b0-7b53-4102-a5be-2ebe7d5b34aa GB_10_Bericht_Titelbogen.indd 1 07.03.11 16:24 VISuAl ConCept age, but also the belief in a future that it is worthwhile investing in today. galenica is convinced that the founda- tions for future success have to be laid in the present. Investing in the future _investing in the future is also a key strategy for survival _no one can predict the future with certainty. even if we in nature. the animal world has various strategies for sometimes wished we could. however, not knowing what dealing with the future and its uncertainties, be these the future holds does not mean passively surrendering to specific mating habits, a sophisticated form of brood one’s fate. galenica believes that it has much in common rearing, or behaviours that simply improve the chances of with the author and pilot antoine de Saint-exupéry on this surviving in an inhospitable environment. this year’s an- point; in the Wisdom of the Sands (citadelle), he wrote: nual report focuses on examples of how animals are in- «Your task is not to foresee the future, but to enable it.» vesting in the present for the future. the images and as- sociated stories give a brief insight into nature’s recipe _experience and expertise enable you to recognise cer- for success. investing in the future, a strategy that has tain trends early on, and draw the appropriate conclu- proven itself over millions of years for nature – and over sions. galenica has proven emphatically in recent years many for galenica as well. that it has this ability. how else would the company have been able to develop from a Swiss pharmaceutical whole- _the galenica group employs around 750 trainees. By saler into the highly specialised international pharmaceu- committing to the training of young people and support- tical company it is today? ing them on their learning path, a company is also invest- ing in the future. With the portraits of young and aspiring _the vision and determination to consistently pursue and professionals, the report illustrates the importance ga- implement this approach are what have made galenica so lenica attaches to the younger generation. successful. this does not only require caution and cour- Securing the future with the right tool _hummingbirds are the smallest birds in existence. in addition to their impressive flying skills and superb shimmering plumage, they have a very striking bill. it varies in shape and length and is often typical for a species. like a key in a lock, each shape of bill fits a specific flower. evolution has thus ensured that hummingbirds do not compete with one another for food, and that each has its own ecological niche. WorldReginfo - 721ec6b0-7b53-4102-a5be-2ebe7d5b34aa GB_10_Bericht_Titelbogen.indd 2 07.03.11 16:24 ContentS AnnuAl report 2010 FInAnCIAl StAtementS 2010 2 _key figures overview Galenica Group 5 _galenica 2010 in brief 91 _key figures 9 _Foreword 92 _consolidated income statement 12 _Vision, values and strategy 93 _consolidated statement of comprehensive income 94 _consolidated statement of financial position reporting 95 _consolidated statement of cash flows 17 _pharma 96 _consolidated statement of changes in equity 29 _logistics 97 _ notes to the consolidated financial statements 35 _retail of the galenica group 43 _other: healthcare information 143 _ report of the statuary auditor on the consolidated financial statements of the galenica group 47 _political environment 50 _corporate governance Galenica ltd. 71 _Sustainability and social responsibility 146 _income statement of galenica ltd. 83 _human resources 147 _Statement of financial position of galenica ltd. 148 _annex to the financial statements of galenica ltd. 153 _ report of the statutory auditor on the financial statements of galenica ltd. Annex 155 _glossary 160 _picture credits and explanatory notes c _ addresses of companies in the galenica group c _masthead galenica annual report 2010 _1 WorldReginfo - 721ec6b0-7b53-4102-a5be-2ebe7d5b34aa GB_10_Bericht_Titelbogen.indd 1 07.03.11 16:24 Key figures OVerVieW in million CHF 2010 2009 galenica group Net sales 3,104.3 2,911.2 _Pharma 578.5 444.7 _Logistics 2,015.0 2,062.3 _Retail 1,089.5 837.7 _Other: HealthCare Information 49.0 43.0 eBiTDA1) 444.9 399.7 EBITDA in % of net sales1) 14.3% 13.7% eBiT1) 324.8 264.9 _Pharma1) 251.7 208.6 _Logistics 27.1 10.6 _Retail 50.9 41.8 _Other: HealthCare Information 7.2 2.2 EBIT in % of net sales1) 10.5% 9.1 % Net profit1) 232.1 209.5 Investment in property, plant and equipment and intangible assets 71.2 70.3 Cash flow from operating activities 336.7 365.3 Cash at 31 December 291.9 66.5 Employees at 31 December (FTE) 5,535 5,373 Balance sheet total1) 3,001.4 2,895.3 Shareholders’ equity1) 925.3 754.3 Equity ratio1) 30.8% 26.1% Net borrowings 947.6 1,223.4 Gearing 102.4% 162.2% galenica Ltd. Profit for the year 52.6 46.2 Shareholders’ equity 340.3 336.4 1) Previous year adjusted due to a definitive purchase price allocation (see page 112) 2_ Key figures overview · Galenica annual report 2010 WorldReginfo - 721ec6b0-7b53-4102-a5be-2ebe7d5b34aa GB_10_Bericht_Titelbogen.indd 2 08.03.11 12:56 net sales eBIt net proFIt in million chF in million chF in million chF 3’1043,104 324.8 2,9112’911 2,7042’704 232.1 2,5292’529 264.9 263.2 209.5 189.2 2’1522,152 2’0892,089 134.9 154.1 103.7 111.6 101.8 80.1 05 06 07 08 09 10 05 06 07 08 09 10 05 06 07 08 09 10 net sales net sales number of employees by business sector by region pharma chF 578.5 million Switzerland chF 3,363.8 million galenica ltd. 40 logistics chF 2,015.0 million europe chF 267.0 million pharma 1,487 retail chF 1,089.5 million america chF 122.6 million logistics 1,060 other: hci chF 49.0 million other countries chF 87.0 million retail 3,848 (galenica group chF 3,104.3 million) (galenica group chF 3,104.3 million) other: hci 199 (galenica group 6,634) eBItDA eBIt Investments by business sector by business sector by business sector pharma chF 331.8 million pharma chF 251.7 million pharma chF 37.2 million logistics chF 42.5 million logistics chF 27.1 million logistics chF 10.5 million retail chF 70.6 million retail chF 50.9 million retail chF 23.8 million other: hci chF 12.4 million other: hci chF 7.2 million other: hci chF 2.9 million (galenica group chF 444.9 million) (galenica group chF 324.8 million) (galenica group chF 71.2 million) galenica annual report 2010 · Key figures overview _3 WorldReginfo - 721ec6b0-7b53-4102-a5be-2ebe7d5b34aa GB_10_Bericht_Titelbogen.indd 3 07.03.11 16:24 Share price performance 1995–2010 _change in chF at the end of each quarter in chF 600 500 300 300 200 100 0 Sept. 95 Dec. 96 Dec. 97 Dec. 98 Dec. 99 Dec. 00 Dec. 01 Dec. 02 Dec. 03 Dec. 04 Dec. 05 Dec. 06 Dec. 07 Dec. 08 Dec. 09 Dec. 10 Share price performance 1995–2010 _change in percentages at the end of each quarter in % 1’600 1’400 1’200 1’000 800 600 400 200 0 Sept. 95 Dec. 96 Dec. 97 Dec. 98 Dec. 99 Dec. 00 Dec. 01 Dec. 02 Dec. 03 Dec. 04 Dec. 05 Dec. 06 Dec. 07 Dec. 08 Dec. 09 Dec. 10 cumulative growth: 1,368% galenica average growth rate p.a.: 21% Swiss performance index (Spi) total shareholder return p.a.: 23% in chF 2010 2009 Share information nominal value per share at 31 December 0.10 0.10 number of outstanding shares1) 6,487,193 6,476,470 Share price at 31 December 565.00 375.00 highest share price for the year 579.00 396.00 lowest share price for the year 364.50 300.00 earnings per share2) 35.51 32.32 Shareholders’ equity per share2) 142.64 116.46 gross dividend per share 8.003) 7.50 pay-out ratio2) 4) 22.3% 23.2% Stock exchange capitalisation at 31 December in thousand chF 3,661,349 2,432,721 1) number of shares after deduction of the number of own, average weighted shares 2) previous year adjusted due to a definitive purchase price allocation (see page 112) 3) according to Board of Directors’ proposal to general meeting on 5 may 2011 4) Dividend in percentages of net profit 4_ Key figures overview · galenica annual report 2010 WorldReginfo - 721ec6b0-7b53-4102-a5be-2ebe7d5b34aa GB_10_Bericht_Titelbogen.indd 4 07.03.11 16:24 Galenica 2010 in brief ViSiOn and ValueS Galenica GrOuP _Galenica is a diversified and highly competent group in Strategy: focus on two strategic axes the healthcare market. With its business activities, Ga- _Specialty Pharma: The central element of the Specialty Pharma lenica generates long-term value and benefits for its cus- strategic axis is the fully integrated, specialised pharma group Vifor Pharma. Vifor Pharma researches, develops and produces its own tomers, patients, business partners, employees and share- and in-licensed pharmaceutical products and markets them world- holders. In pursuing its goals, the Galenica Group is guided wide, concentrating on three main business areas: iron deficiency by the following values: a long-term orientation, innova- and iron deficiency anaemia, the activities of the pharmaceutical tion, focus on success, flexibility and sustainability.
Recommended publications
  • Market Notice Date: 14 November 2019 Market Notice Number: 112/2019
    Market Notice Date: 14 November 2019 Market Notice Number: 112/2019 Equiduct Universe Change Please see today's changes below effective 18 November 2019: Trading Reporting MIC Settlement Trading Settlement Tick Size Change/ Security Name ISIN Home Market Symbol Country Currency Currency table Action ABB LTD ABBNz CH0012221716 XSWX EQTB CH CHF CHF ESMA_E Deletion ABB ABBs CH0012221716 XSTO EQTB SE SEK SEK ESMA_E Deletion ADECCO SA ADENz CH0012138605 XSWX EQTC CH CHF CHF ESMA_E Deletion AMS AG AMSz AT0000A18XM4 XSWX EQTC CH CHF CHF ESMA_E Deletion ARYZTA AG ARYNz CH0043238366 XSWX EQTB CH CHF CHF ESMA_E Deletion JULIUS BAER GRUPPE AG BAERz CH0102484968 XSWX EQTC CH CHF CHF ESMA_E Deletion BALOISE-HLDGS BALNz CH0012410517 XSWX EQTC CH CHF CHF ESMA_D Deletion BARRY CALLEBAUT AG BARNz CH0009002962 XSWX EQTC CH CHF CHF ESMA_D Deletion BB BIOTECH BBZAd CH0038389992 XETR EQTB DE EUR EUR ESMA_D Deletion BB BIOTECH BIONz CH0038389992 XSWX EQTB CH CHF CHF ESMA_D Deletion BASILEA PHARMACEUTICA AG BSLNz CH0011432447 XSWX EQTC CH CHF CHF ESMA_D Deletion BUCHER INDUSTRIES BUCNz CH0002432174 XSWX EQTC CH CHF CHF ESMA_D Deletion COMPAGNIE FINANCIERE RICHEMONT CFRz CH0210483332 XSWX EQTC CH CHF CHF ESMA_E Deletion CLARIANT CLNz CH0012142631 XSWX EQTC CH CHF CHF ESMA_E Deletion CEMBRA MONEY BANK AG CMBNz CH0225173167 XSWX EQTC CH CHF CHF ESMA_D Deletion CREDIT SUISSE GROUP AG CSGNz CH0012138530 XSWX EQTC CH CHF CHF ESMA_E Deletion DKSH HOLDING DKSHz CH0126673539 XSWX EQTC CH CHF CHF ESMA_D Deletion DORMA+KABA HOLDING AG DOKAz CH0011795959 XSWX EQTC CH CHF
    [Show full text]
  • Full Portfolio Holdings
    Hartford Multifactor International Fund Full Portfolio Holdings* as of August 31, 2021 % of Security Coupon Maturity Shares/Par Market Value Net Assets Merck KGaA 0.000 152 36,115 0.982 Kuehne + Nagel International AG 0.000 96 35,085 0.954 Novo Nordisk A/S 0.000 333 33,337 0.906 Koninklijke Ahold Delhaize N.V. 0.000 938 31,646 0.860 Investor AB 0.000 1,268 30,329 0.824 Roche Holding AG 0.000 74 29,715 0.808 WM Morrison Supermarkets plc 0.000 6,781 26,972 0.733 Wesfarmers Ltd. 0.000 577 25,201 0.685 Bouygues S.A. 0.000 595 24,915 0.677 Swisscom AG 0.000 42 24,651 0.670 Loblaw Cos., Ltd. 0.000 347 24,448 0.665 Mineral Resources Ltd. 0.000 596 23,709 0.644 Royal Bank of Canada 0.000 228 23,421 0.637 Bridgestone Corp. 0.000 500 23,017 0.626 BlueScope Steel Ltd. 0.000 1,255 22,944 0.624 Yangzijiang Shipbuilding Holdings Ltd. 0.000 18,600 22,650 0.616 BCE, Inc. 0.000 427 22,270 0.605 Fortescue Metals Group Ltd. 0.000 1,440 21,953 0.597 NN Group N.V. 0.000 411 21,320 0.579 Electricite de France S.A. 0.000 1,560 21,157 0.575 Royal Mail plc 0.000 3,051 20,780 0.565 Sonic Healthcare Ltd. 0.000 643 20,357 0.553 Rio Tinto plc 0.000 271 20,050 0.545 Coloplast A/S 0.000 113 19,578 0.532 Admiral Group plc 0.000 394 19,576 0.532 Swiss Life Holding AG 0.000 37 19,285 0.524 Dexus 0.000 2,432 18,926 0.514 Kesko Oyj 0.000 457 18,910 0.514 Woolworths Group Ltd.
    [Show full text]
  • Corporate Social Responsibility Report 2016 Walgreens Boots Alliance Is the First Global Pharmacy-Led, Health and Wellbeing Enterprise
    Corporate Social Responsibility Report 2016 Walgreens Boots Alliance is the first global pharmacy-led, health and wellbeing enterprise. Our purpose is to help people across the world lead healthier and happier lives. Our 2016 Corporate Social Responsibility Report covers the fiscal year that ended 31 August 2016. In this year’s report: Overview Marketplace Introduction ...................................................1 Our CSR goals .............................................2 28 Our vision, purpose and values ................3 Our approach to CSR .................................4 Contributing to the United Nations Sustainable Development Goals .............6 Transparency ........................................... 30 Our impact ...................................................8 Ethical Sourcing ...................................... 30 ........................... About our Company ................................. 10 External Stakeholders 31 Stakeholder engagement ....................... 12 Workplace Community 32 14 Employee Health and Wellbeing ........ 34 Equal Opportunities .............................. 36 Health and Wellbeing ............................. 16 Health and Safety ...................................37 Young People ........................................... 17 ...................................... Cancer Programs .....................................20 About this report 38 Data management process ................ 38 Environment Data ............................................................ 38 Community data
    [Show full text]
  • OSB Participant List by Research Area
    OSB Participant List by Research Area Contact Centers (CC) • AARP • Air Products and • American Drug Stores Chemicals • AAA • ABB • American Electric Power • Airbus • Accor • Abbott • American Express • Alcatel Lucent • American Electric Power • Abengoa • American International • Alcoa Group • American International • Abu Dhabi National Group Energy Company • Alcon • American Stores Company • Austin Energy • ACC Limited • Alfa • American Water • Bank of America • Access Insurance Holdings • Algonquin Power & • Amgen Utilities • Blue Cross Blue Shield • Accord Holdings • AMIL • ALH Group • Charles Schwab & • ACE • AmInvestment Bank Company • Alitalia • Acea • AMR • Citigroup • ALK Abello • Acer • Amssi • Citizens Gas • Alkermes • Acxiom • Amtran Logistics • Clarke American • Allergan • Adelaide Clinic Holdings • Andrew Corporation • CPS Energy • Alliance & Leicester • Adidas • Anglian Water Services • Direct Energy • Alliance Boots • Advance Food Company • Anritsu • Federal Reserve Bank of • Alliant Techsystems Minneapolis • Advance Publications • Anschutz • Allianz • John Deere • Advanced Coating • Apache • Allied Irish Banks • Technologies Louisville Water Company • Apex Equity Holdings • Advanced Semiconductor • Allstate Insurance • Manila Electric Company Engineering Company • Apple • • • Mellon Financial Adventist Health System Ally Financial • Arcadia Housing • • • MetLife Aegon Alon USA Energy • Arcos Dorados Holdings • • • Morgan Stanley AEON AlpTransit Gotthard • Ardent Health Services • • • NetBank Aera Energy Alstom • Argos •
    [Show full text]
  • Local Businesses – Large and Small
    Local Businesses – Large and Small The details of the local businesses documented below have been researched by the Local History Group. Thomas Glover & Son Thomas Glover & Son, elastic web and fabric manufacturers appeared in the Post Office Directory for Nottinghamshire in 1855. The company is recorded as having several addresses in Nottingham, however it had disappeared from the directory by 1900, returning in 1925 described as a surgical hosier in Chesterfield Street, Carlton. The firm remained at that address until the 1970s. The company’s buildings were on both sides of Chesterfield Street but are now demolished, new houses being built on the side. Turney Brothers In 1861 two brothers, Edward and John Turney built a tannery and began to make leather on a site next to the River Trent and the adjacent canal in Nottingham, known as Sneinton Island. The first buildings took up only a fraction of the space that by the 1920s had developed into a large site with labour-saving machinery imported from many countries. They traded under the name of Turney Brothers and had offices in London, Leicester and Manchester. Edward left some years after the commencement of the company and the driving force was John Turney who was in sole charge for over a quarter of a century. In 1888 the company re-organised into a Limited Company, John being chairman. John led an exceptionally distinguished social, political and commercial life. He was a member of Nottingham Corporation for 46 years, and became Sheriff and then Alderman in 1879 and Mayor for two years 1886 – 1888.
    [Show full text]
  • Marktbericht Aktien Schweiz Small Mid Cap 01 2017
    BERICHT AKTIEN SCHWEIZ SMALL & MID CAP Albin Kistler Aktien Small & Mid Cap Schweiz Quartalsbericht 1/2017 Benjamin Ginesta Als Aktienanalyst ist Benjamin Ginesta seit 2012 Die periodisch erscheinenden Markteinschätzun- bei Albin Kistler tätig und ist zuständig für die gen & Anlageberichte stehen auf der Website von Investitionen im Bereich Gesundheit. In der Funk- Albin Kistler als PDF-Download zur Verfügung: tion als Berater im Bereich Asset Management ist www.albinkistler.ch/markteinschaetzung er zudem verantwortlich für Mandate von Institu- tionellen Kunden. Marktbericht Albin Kistler Aktien Small & Mid Cap Schweiz Breite Hausse in Schweizer Aktien bei den Small & Mid Cap Aktien sind hingegen- Der Schweizer Aktienmarkt stieg im ersten Quar- breiter verteilt. Den grössten Einfluss (Kontributi- tal 2017 auf breiter Front. Der Swiss Performance on +1.09%) hatte das Chemieunternehmen Si- Index (SPI) erzielte eine Rendite von +7.50%. Die ka(+23.9%). Ebenfalls beachtlich sind die Einflüsse Small & Mid Cap Aktien, gemessen am SPI Extra, der beiden Index-Leichtgewichte AMS und Lo- stiegen sogar um +9.76%. Mit einer Mehrendite gitech aus dem Technologiesektor. Obwohl die von +2.26% übertrafen die Schweizer Small & Mid Gewichtungen im SPI Extra-Index bei 1.1% bzw. Cap Aktien ein weiteres Mal den Gesamtmarkt. 1.9% lagen, wirkten sich die Anstiege von +87% bzw. +24% dieser Aktien substantiell auf die Ge- samtperformance des SPI Extra aus. In der Sek- torbetrachtung erzielten die Industriefirmen den grössten Beitrag zur Indexrendite. Nebst dem
    [Show full text]
  • Corporate Finance Guide 2021 CORPORATE FINANCE GUIDE SPECIAL | CORPORATE
    01/06/2021 15:30 15:30 01/06/2021 01/06/2021 1 1 cover.indd cover.indd Guide Guide Finance Finance Corporate Corporate MIDLANDS BUSINESS INSIDER www.midlandsbusinessinsider.com JULY 2021 JULY midlands businessinsider WEST ™ MIDLANDS insiderEDITION VOL.29 NO.7 £10 JULY 2021 West Midlands Mayor What does business want from Andy Street’s second term? CITY OF CULTURE CITY OFCULTURE Wolverhampton The new home of green construction | SMEGUIDE Mental health | MENTAL HEALTH HEALTH MENTAL Helping a colleague on the edge | RESIDENTIAL AWARDS RESIDENTIALAWARDS | CORPORATE FINANCEGUIDESPECIAL CORPORATE Guide Guide 2021 Corporate Finance Corporate MIDLANDS | CIRCULARECONOMY FIREDHOW A YEAR AS CITY OF CULTURE UP! IS VOL.29 N VOL.29 SPARKING GROWTH IN COVENTRY O 7 MBI July 2021 cover MASTER.indd 1 02/06/2021 15:00 Optimising outcomes for our clients no matter what their destination DLA Piper has been the No 1 M&A law firm, both in the UK and globally, for each of the past 11 years. Trusted adviser to: Put simply, we do things that other law firms cannot. Times 2 SISTERS FOOD GROUP may change, but our qualities do not. Our clients trust us with Advised on the GBP246m sale of part of Fox’s Biscuits to their most important, strategic and transformational M&A and Ferrero Group. ECM transactions. We use our market and sector intelligence and unrivalled deal execution experience to drive and obtain NOBLE GROUP optimal outcomes for our clients, no matter what the deal type, Advised on the sale of chilled dessert brand Gü to Exponent the transaction process, the geography or the counter-party.
    [Show full text]
  • Download Annual Report 2013
    Annual Report 2013 Our goal Our goal is to become Central and Eastern Europe’s leading spirits company – commanding a major stake in each of our core operating markets and making our presence felt in the wider global market. Contents Strategic report Chairman’s statement 02 Group at a glance 04 Our “millionaire” brands 06 Our heritage 08 Chief Executive Officer’s statement 10 Our business model 14 Strategy and KPIs 16 Our markets 18 HIGHLIGHTS Spirits market overview 20 Regional reviews Poland 22 17.4 m €340.5m Czech Republic 24 Italy 26 9 LITRE CASES NET SALES REVENUE Other 27 +11.4% +16.4% Operations 28 2012: 15.6m 9 litre cases 2012: €292.4m Our people 29 Corporate responsibility 30 €83.7m €47.7m Financial review 32 Principal risks 36 ADJUSTED EBITDA* OPERATING PROFIT Directors and +22.3% -44.2% Company Secretary 42 2012: €68.4m 2012: €85.4m Senior management 44 Corporate governance 46 Chairman’s letter 46 €74.4 m €8.9m Corporate governance framework 47 ADJUSTED EBIT* PROFIT FOR THE YEAR Audit Committee report 52 +26.7% -66.0% 2012: €58.7m 2012: €26.2m Nomination Committee report 56 Directors’ remuneration * Stock Spirits Group uses alternative performance measures as key financial indicators to assess the underlying performance of the Group. These include adjusted EBITDA, adjusted EBIT and adjusted free cash flow. report 57 The narrative in the Annual Report & Accounts is based on these alternative measures and an explanation is set out in note 7 to the consolidated financial statements included in the Annual Report & Accounts.
    [Show full text]
  • 2019 Switzerland Spencer Stuart Board Index 
    2019 Switzerland Spencer Stuart Board Index About Spencer StuArt Spencer Stuart has had an uninterrupted presence in Switzerland since 1959, when it opened its Zurich office. Spencer Stuart is one of the world’s leading executive search consulting firms. We are trusted by organisations around the world to help them make the senior-level leadership decisions that have a lasting impact on their enterprises. Through our executive search, board and leadership advisory services, we help build and enhance high-performing teams for select clients ranging from major multinationals to emerging companies to nonprofit institutions. Privately held since 1956, we focus on delivering knowledge, insight and results though the collaborative efforts of a team of experts — now spanning more than 60 offices, over 30 countries and more than 50 practice specialties. Boards and leaders consistently turn to Spencer Stuart to help address their evolving leadership needs in areas such as senior-level executive search, board recruitment, board effectiveness, succession planning, in-depth senior management assessment and many other facets of organisational effectiveness. For more information on Spencer Stuart, please visit www.spencerstuart.com. Social Media @ Spencer Stuart Stay up to date on the trends and topics that are relevant to your business and career. @Spencer Stuart © 2020 Spencer Stuart. All rights reserved. For information about copying, distributing and displaying this work, contact: permissions@spencerstuart.com. 1 spencer stuart Contents 3 Foreword
    [Show full text]
  • Vontobel Swiss Small Companies A
    Asset Management / Monthly Factsheet as at 31/08/2020 Vontobel Swiss Small Companies A Approved for Wholesale/Retail investors in: CH. Investment objective Net Performance of A Share (in CHF and %) This equity fund aims to generate long-term capital growth while re- 1 mth. YTD 2019 2018 2017 3 y. 5 y. since specting risk diversification. p.a. p.a. inception Fund 6.6 4.2 21.6 -21.3 23.0 2.5 7.2 1206.0 Key features Index 7.4 6.2 20.1 -19.1 26.3 4.0 9.4 1184.8 The fund invests in a concentrated portfolio mainly including stocks of smaller, innovative Swiss companies which are among the leaders in their 09.15 – 08.16 09.16 – 08.17 09.17 – 08.18 09.18 – 08.19 09.19 – 08.20 industry, offer interesting profitability growth potential, and whose stock Fund 14.3 15.2 8.0 -13.6 15.5 prices have attractive upside potential versus the estimated enterprise Index 15.6 20.5 6.3 -10.0 17.4 values at the time of the investment. Benchmark: ZKB Swiss Small Cap Index Source: Vontobel Asset Management AG. Past performance is not a guide to current or future Approach performance. The performance data do not take account of the commissions and costs incurred The specialized and seasoned investment team takes long-term high- on issue and redemption. The return of the fund can be a result of currency fluctuations rise or fall. conviction investment decisions based on in-depth research.
    [Show full text]
  • Stoxx® Europe Low Risk Weighted 100 Index
    STOXX® EUROPE LOW RISK WEIGHTED 100 INDEX Components1 Company Supersector Country Weight (%) BARRY CALLEBAUT Food, Beverage & Tobacco CH 1.40 KUEHNE + NAGEL Industrial Goods & Services CH 1.35 ALLREAL HLDG Real Estate CH 1.35 NESTLE Food, Beverage & Tobacco CH 1.33 SCHINDLER P Industrial Goods & Services CH 1.31 BANQUE CANTONALE VAUDOISE Banks CH 1.20 EMS-CHEMIE HLDG Chemicals CH 1.16 NOVO NORDISK B Health Care DK 1.16 GALENICA SANTE AG Personal Care, Drug & Grocery Stores CH 1.16 SWISSCOM Telecommunications CH 1.15 AHOLD DELHAIZE Personal Care, Drug & Grocery Stores NL 1.14 KONE B Industrial Goods & Services FI 1.14 DANONE Food, Beverage & Tobacco FR 1.13 HERMES INTERNATIONAL Consumer Products & Services FR 1.12 NOVOZYMES Health Care DK 1.11 GEBERIT Construction & Materials CH 1.11 SWISS PRIME SITE Real Estate CH 1.11 NOVARTIS Health Care CH 1.10 SGS Industrial Goods & Services CH 1.10 AXFOOD Personal Care, Drug & Grocery Stores SE 1.09 STADLER RAIL AG Industrial Goods & Services CH 1.08 WOLTERS KLUWER Media NL 1.08 SANOFI Health Care FR 1.07 KONINKLIJKE DSM Chemicals NL 1.07 DEUTSCHE TELEKOM Telecommunications DE 1.06 GIVAUDAN Chemicals CH 1.05 PERNOD RICARD Food, Beverage & Tobacco FR 1.05 ACKERMANS & VAN HAAREN Financial Services BE 1.05 UNIPER Utilities DE 1.05 SAINSBURY (J) Personal Care, Drug & Grocery Stores GB 1.04 ELISA CORPORATION Telecommunications FI 1.04 ADMIRAL GRP Insurance GB 1.04 HENKEL PREF Consumer Products & Services DE 1.04 IMCD Chemicals NL 1.04 JDE PEET S Food, Beverage & Tobacco NL 1.04 VOPAK Industrial Goods
    [Show full text]
  • Glaxosmithkline Aims to Divest Many OTC Brands
    OTC11-02-11p1&28FIN.qxd 8/2/11 11:52 Page 1 11 February 2011 COMPANY NEWS 3 GlaxoSmithKline aims to Valeant expands in CEE 3 with PharmaSwiss deal J&J loses sales of US$1.1bn 4 Boots faces up to tough market 5 divest many OTC brands Key brands boost Novartis OTC sales 6 GSK consumer races ahead 7 laxoSmithKline intends to divest non- to divest the non-core brands as soon as pos- Taisho holds steady in weak market 8 Gcore OTC brands with combined an- sible – hopefully before the end of the year – Vicks shipments lift OTC at P&G 9 nual sales of £500 million (C593 million). depending on buyer interest. Perrigo plans spring Allegra launch 10 Chief executive officer Andrew Witty said The announcement came as GlaxoSmith- Consumer Care grows at Merck & Co 11 the move would enable the company’s Con- Kline reported a 7% rise – 5% at constant ex- Omega reports strong quarter 12 sumer Healthcare division to focus more effec- change rates – in 2010 sales at the Consumer Winter woes hit Boiron 13 tively on its “priority or global” brands as well Healthcare division to £5.01 billion. Sales in Pfizer wants Consumer 14 as its operations in emerging markets. Consumer Healthcare’s OTC Medicines busi- to prove worth A spokesperson for GlaxoSmithKline told ness grew by 5% – 3% at constant exchange OTC bulletin that the company was currently rates – to £2.46 billion. GENERAL NEWS 15 compiling the lists of priority and non-core OTC brands, and hoped to release more details Recent deals with Meda and Valeant Perrigo faces lawsuit over 15 in the second quarter of the year.
    [Show full text]